Why Do Care Inspectors Focus on eMAR Charts?

Medication administration remains one of the highest‑risk areas in social care, and regulators have strengthened their expectations around accurate, legible and complete Medication Administration Records (MARs). Both the Care Quality Commission (CQC) and the Care Inspectorate now explicitly link poor medication records to breaches of Regulation 12 (Safe Care and Treatment) and Regulation 17 (Good Governance), highlighting them as key indicators of unsafe practice.

Inspectors place emphasis on MAR charts for one key reason: safety. Up‑to‑date medication records ensure that every care worker knows which medicines were taken, when, and at what dose. This is essential for preventing double‑dosing, missed doses, and unmonitored changes in treatment.

The CQC's 2025 guidance stresses that MARs, whether paper or electronic, must always be:

• Legible, clear and accurate
• Correctly dated and time‑stamped
• Signed immediately after administration
• Completed for both medicines given and refused

The Care Inspectorate’s 2025 record‑keeping updates similarly emphasise that adult services must keep clear, auditable medication documentation as part of safe service delivery.
Poor documentation creates immediate safeguarding concerns: if inspectors cannot determine whether a person received their medicine, they must assume the provider cannot guarantee safe care.

Paper MAR charts continue to present challenges that are highlighted in inspection reports:

• Handwritten notes may be cramped into small boxes or recorded in varying styles across staff, increasing the likelihood of misinterpretation. The CQC warns that MARs must be legible and standardised, which paper formats struggle to guarantee.
• Regulators consistently identify missed entries, unsigned doses, or unclear refusal reasons as unsafe practice. Missed signatures are also cited in 2025 audits as one of the most common medication errors seen in inspections.
• When doses or medicines change, paper MARs may become instantly outdated. Pharmacy‑printed charts can be accurate only at the time of printing, and mid‑cycle changes often result in multiple overlapping charts—one of the “problems to watch out for” noted in 2024/2025 good‑practice guidance.
• Homecare teams face additional communication challenges across prescribers, pharmacies, and rotating care workers. The CQC’s 2025 update emphasises that timely, clear documentation is vital, especially where multiple care workers visit a person at different times. When a MAR chart is unclear, incomplete, or contradictory, inspectors can neither confirm medication safety nor verify that providers understand what is being administered—triggering enforcement actions.

Digital records are now strongly encouraged across UK care services. The CQC’s 2025 update on digital MARs highlights that electronic systems promote clarity, consistency, and safety, reducing the risk of error through standardisation and instant updates.

1. No more illegible handwriting or inconsistent formats - Digital entries ensure standardised, readable records—one of the core CQC requirements.
2. Automatic time‑stamps and audit trails - eMAR creates a record of who administered medication and when, helping providers demonstrate compliance during inspections.
3. Instant updates after prescription changes - Electronic charts update centrally, ensuring all care workers have access to current instructions, critical in community care settings.
4. Real‑time alerts for missed or late doses - Digital MARs flag exceptions immediately, allowing managers to investigate quickly—supporting Regulation 12 and governance oversight.
5. Reduced administrative burden - Electronic systems remove the need for physically replacing MAR sheets, reducing printing, travel costs and record‑management risks.

In 2025–2026, UK health and care regulators have made it unambiguously clear: accurate medication records are the foundation of safe care. With strengthened guidance from the CQC, NICE and NHS England, poor MAR documentation is now recognised as a direct risk to service users, and a major trigger for regulatory action.

For providers wanting to reduce risk, improve compliance and modernise practice, transitioning from paper MAR charts to a well‑implemented eMAR system is now widely regarded as best practice across the sector.

Access Medication Management offers a powerful, intuitive, and fully compliant digital medications platform designed to meet these expectations. By providing real‑time visibility, automated alerts, accurate audit trails and seamless communication between teams, Access Medication Management helps ensure medication rounds are safer, faster and consistently aligned with regulatory requirements.

Ready to strengthen your medication safety and compliance?

Explore Access Medication Management today and see how it can transform your service’s medication processes.